Navigation Links
Biologist finds plant polymerases IV and V are really variants of Polymerase II

It's a little like finding out that Superman is actually Clark Kent. A team of biologists at Washington University in St. Louis has discovered that two vital cellular components, nuclear RNA Polymerases IV and V (Pol IV and V), found only in plants, are actually specialized forms of RNA Polymerase II, an essential enzyme of all eukaryotic organisms, including humans.

"We've caught evolution in the act," said Craig Pikaard, Ph.D., Washington University professor of biology in Arts & Sciences. "We've known for decades that RNA Polymerases I, II and III are found in all eukaryotes, but it's only over the past several years that we've been aware that plants have two more nuclear polymerases, Pol IV and Pol V. Now it is clear that these enzymes evolved from Pol II over the past several hundred millions years. This is a new snapshot into the evolution of RNA polymerases, which are the enzymes responsible for decoding the information stored in the chromosomes".

Analyzing purified Pol IV and Pol V by a sophisticated technique known as tandem mass spectrometry, the Pikaard lab and a team of collaborators at Pacific Northwest National Laboratory, led by Ljiljana Paa-Toli?, discovered 12 subunits in both Pol IV and Pol V that correspond one-for-one to the 12 subunits of Pol II. Some of the Pol IV and Pol V subunits are encoded by the same genes as the corresponding Pol II subunits, but others come from duplicated Pol II subunit genes that have changed over time. Overall, four subunits of Pol IV are distinct from their Pol II counterparts, six subunits of Pol IV are different from their Pol II counterparts, and four subunits differ between Pol IV and Pol V. Yet, all of the Pol IV and Pol V subunits are "apples that haven't fallen far from the Pol II tree."

The finding is important because it reveals more about the roles played by RNA in complex organisms. RNA polymerases are the enzymes responsible for making RNA from DNA templates. They are key players in determining which genes get switched on and which get turned off. RNA Polymerase II, for instance, is vital in the production of messenger RNAs that specify the amino acid sequences of each of the proteins in the cell. Despite having evolved from Pol II, Pol IV and V do not appear to be involved in protein synthesis, or to be absolutely essential for life. Instead, they have taken on specialized roles in gene silencing in plants. This is important to prevent the expression of potentially harmful genes, such as virus-derived "jumping genes" known as retrotransposons, and invading nucleic acids, such as the genomes of replicating viruses. The Pikaard lab has shown that Pol IV is required for the production of small interfering RNAs (abbreviated as siRNAs) that specify the silencing of matching DNA sequences, whereas Pol V makes longer RNAs that are thought to pair with the siRNAs at the affected chromosomal sites.

Pikaard and his colleagues' work may have implications for applied medical research. For instance, gene therapy procedures sometimes use retroviral vectors as a way of introducing a foreign gene to replace a function impaired by disease. Often this foreign gene, called a transgene, restores the missing function for a while and then unexpectedly goes silent. The silencing process may have parallels to the pathway in plants that makes use of Pol IV and Pol V. Pikaard hypothesizes that Pol II accomplishes the functions of Pol IV and Pol V in other non-plant eukaryotes.

The research revealing the subunit compositions of RNA Polymerases II, IV and V in the plant genus Arabidopsis was published online Dec. 23, 2008 in Molecular Cell. The work was supported by the National Institutes of Health and the U.S. Department of Energy.

Pikaard's laboratory has been investigating the functions of Pol IV and Pol V since playing a leading role in their discovery in 2005. The Dec. 23 Molecular Cell paper is one of three related papers published by the Pikaard lab in rapid succession. In a paper published Nov. 14, 2008 in Cell, Pikaard and his colleagues explain how Pol IV and Pol V work together to use the non-coding region of DNA to prevent destructive, virus-derived genes from being activated. Then in a paper published Dec. 4 in Molecular Cell, the Pikaard lab announced a breakthrough in understanding the phenomenon of nucleolar dominance, the silencing of an entire parental set of ribosomal RNA genes in a hybrid plant or animal. That study is one of the first to demonstrate how siRNAs can play a role in controlling the dosage of vital genes, and not just harmful genes, and implicates the pathway in which Pol IV and Pol V function. The research has been supported by the National Institutes of Health and by the National Science Foundation.


Contact: Craig Pikaard
Washington University in St. Louis

Related medicine news :

1. Cell biologists identify new tumor suppressor for lung cancer
2. Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institutes Samuel L. Pfaff, Ph.D. - to its International Research Consortium
3. Microbiologists receive top Canadian recognition
4. UCR cell biologist co-leads joint international conference on wound healing
5. Boston College biologists build a better mouse model for cancer research
6. Biologists Discover How Dengue Virus Matures
7. Stanford biologist awarded 2008 Sophie Prize in Norway
8. New book by UCR biologist discusses 12 diseases that impacted humanity
9. Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says
10. First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says
11. Researcher Finds Most Will Inflict Pain on Others If Prodded
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the ... 2016 Building Better Radiology Marketing Programs meeting will showcase some of ... 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session on ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: